Glaucoma — characterized by elevated intraocular pressure (IOP) that damages the optic nerve over time — is one of the most frequently cited medical justifications for cannabis use, and one of the original qualifying conditions for many state medical cannabis programs. The science, however, tells a more complicated story.
What the Research Shows
Cannabis does reduce intraocular pressure. Studies dating to the 1970s demonstrated IOP reductions of 25–30% following cannabis smoking or oral THC administration [1]. This finding is real, replicated, and not in dispute. The problem is duration: the effect lasts only 3–4 hours, requiring dosing 6–8 times per day to maintain therapeutic IOP levels around the clock — the clinical requirement for glaucoma management.
The American Academy of Ophthalmology (AAO) does not recommend cannabis for glaucoma management, noting that no studies have demonstrated that cannabis use prevents optic nerve damage or vision loss, and that existing IOP-lowering medications provide sustained 24-hour control with fewer systemic side effects [2].
The Blood Pressure Problem
Cannabis also lowers blood pressure, which can reduce ocular perfusion pressure — the pressure driving blood flow to the optic nerve. In some patients, particularly those with normal-tension glaucoma, this reduction in perfusion pressure may actually worsen optic nerve ischemia, potentially accelerating damage rather than preventing it.
Key Evidence Points
- Cannabis reduces IOP by 25–30% — effect is real and well-documented since the 1970s [1]
- Duration of effect: 3–4 hours only; 6–8 doses/day would be required for full-time coverage
- AAO does not recommend cannabis for glaucoma — no evidence of optic nerve protection [2]
- Cannabis-induced blood pressure reduction may reduce ocular perfusion in normal-tension glaucoma
- Existing topical medications (prostaglandin analogs) provide superior 24-hour IOP control
Citations
- Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. JAMA. 1971;217(10):1392. PubMed 5109652
- American Academy of Ophthalmology. Marijuana in the Treatment of Glaucoma. Policy Statement 2014. aao.org